Canada markets close in 1 hour 2 minutes

Stoke Therapeutics, Inc. (STOK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
11.57-0.37 (-3.10%)
As of 02:58PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
8,780
8,780
12,405
0
0
Operating Expenses
Research Development
82,231
82,231
77,837
54,168
32,197
Selling General and Administrative
41,322
41,322
38,924
31,897
20,847
Total Operating Expenses
123,553
123,553
116,761
86,065
53,044
Operating Income or Loss
-114,773
-114,773
-104,356
-86,065
-53,044
Total Other Income/Expenses Net
166
166
167
140
101
Income Before Tax
-104,699
-104,699
-101,067
-85,805
-52,243
Income from Continuing Operations
-104,699
-104,699
-101,067
-85,805
-52,243
Net Income
-104,699
-104,699
-101,067
-85,805
-52,243
Net Income available to common shareholders
-104,699
-104,699
-101,067
-85,805
-52,243
Basic EPS
-2.60
-2.38
-2.60
-2.34
-1.56
Diluted EPS
-2.60
-2.38
-2.60
-2.34
-1.56
Basic Average Shares
38,897
43,995
38,897
36,739
33,488
Diluted Average Shares
38,897
43,995
38,897
36,739
33,488